Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Total Current Liabilities (2022 - 2026)

Updated

Eupraxia Pharmaceuticals (EPRX) reported Total Current Liabilities of $8.55 million for the quarter ended Jun 30, 2026, up 226.6% from $2.62 million a year earlier and up 16.1% from the prior quarter.

Analysis

Eupraxia Pharmaceuticals (EPRX) Total Current Liabilities (2022 - 2026) Analysis & Trends

As of Dec 31, 2025, Eupraxia Pharmaceuticals posted Total Current Liabilities of $5.63 million, up 81.4% from the prior year.

  • Total Current Liabilities has a three-year compound annual growth rate of 22.5% (years ended Dec 2022 to Dec 2025).
  • By year, Total Current Liabilities came in at $3.1 million in the year ended Dec 31, 2024 (-84.0%), $19.37 million in the year ended Dec 31, 2023 (+533.5%) and $3.06 million in the year ended Dec 31, 2022.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Total Current Liabilities since the quarter ended Jun 30, 2024.
  • Year over year, Total Current Liabilities has now increased in each of the last four quarters, with growth averaging 50.5% over the last seven quarters.
  • The high point for year-over-year Total Current Liabilities in five years was the quarter ended Dec 31, 2023 (growth of 533.5%); the low point was the quarter ended Mar 31, 2025 (a decline of 88.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $7.36 million (quarter ended Mar 31, 2026), $5.63 million (quarter ended Dec 31, 2025) and $3.81 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Eupraxia Pharmaceuticals 328.04 Mn 326.44 Mn - 8.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.55 Mn
Mar 31, 2026 7.36 Mn
Dec 31, 2025 5.63 Mn
Sep 30, 2025 3.81 Mn
Jun 30, 2025 2.62 Mn
Mar 31, 2025 2.20 Mn
Dec 31, 2024 3.10 Mn
Sep 30, 2024 2.37 Mn
Jun 30, 2024 11.60 Mn
Mar 31, 2024 18.53 Mn
Dec 31, 2023 19.37 Mn
Dec 31, 2022 3.06 Mn
API Access

Eupraxia Pharmaceuticals Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=EPRX&period=max&api_key=YOUR_API_KEY